TrialJournal of clinical pharmacology2021

Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid.

Hidefumi Kasai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.